Remove 2019 Remove Controlled Substances Remove Patient Care
article thumbnail

Omnicell and Fresenius Kabi Join Forces to Improve Controlled Substance Management

Omnicell

Tara Plappert Product Marketing Manager Hospitals and clinics face a significant challenge when dealing with controlled substances. In 2019, more than 148 million doses of medicine were lost , endangering both patients and employees. And according to the 2019 Drug Diversion Digest , 47.2

article thumbnail

Summer 2021 – Transforming Pharmacy Through Innovation and Superior Customer Experience

Omnicell

Latest enhancements in the Summer Release are designed to improve medication management workflows and patient safety, allowing clinicians to provide greater patient care and reduce job-related stress and burnout. healthcare system, compromising both patient and workforce safety. Improved Efficiency The U.S.

article thumbnail

Psychedelic research: evaluating the fast-evolving regulatory roadmap

European Pharmaceutical Review

Most psychedelic drugs are Schedule I controlled substances, which means that very strict legal and regulatory controls accompany their use” Some psychedelics originate in nature and have been used by Indigenous cultures for thousands of years; others are manipulated or manufactured. About the authors.